The Largest CTEPH Program in the Eastern United States
Temple Health is a national leader in the care of patients with a rare form of pulmonary hypertension called CTEPH (chronic thromboembolic pulmonary hypertension). In this condition, clots form in blood vessels of the lungs — raising blood pressure to dangerous levels, impairing breathing, and potentially causing right heart failure. Left untreated, CTEPH can be fatal.
Temple offers an alternative: potentially curing CTEPH — with one of the most experienced CTEPH teams in the country, and the largest CTEPH program in the Eastern United States. That’s why patients across the country seek out Temple’s specialists for this life-threatening condition.
An Advanced Treatment for a Complex Disease
Temple's CTEPH team — led by Paul Forfia, MD and Anjali Vaidya, MD — offers expert management of this condition, which sets us apart from other programs.
Our patients benefit from the full spectrum of care: accurate diagnosis, experienced medication management, balloon pulmonary angioplasty (BPA), and a delicate surgical procedure called PTE (pulmonary thromboendarterectomy), which removes life-threatening clots from the lungs.
Few medical centers perform this curative surgery, let alone offer this comprehensive program of diagnosis and treatment. Temple’s CTEPH team has saved more than 370 lives to date — achieving exceptional outcomes.
At Temple Health, we offer solutions to complex conditions.
